DIAGNOSTIC KIT Reagent 'drug-peptide ELISA TEST' TO DETERMINE addicts

摘要

1. diagnostic reagent kit u0434u043bu00a0 physical addiction to drugs, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 that contains antibodies to the two u044du043fu0438u0442u043eu043fu0430u043c u043cu0434u043eu0440 u043fu0435u043fu0442u0438u0434u043du043eu0433u043e u0440u0435u043au043eu043cu0431u0438u043du0430 fragment u043du0442u043du043eu0433u043e opiate mu / delta u0440u0435u0446u0435u043fu0442u043eu0440u0430, u0438u043cu043cu043eu0431u0438u043bu0438u0437u043eu0432u0430u043du043du044bu0435 on solid medium, and the reactant u0434u043bu00a0 u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 u043fu0440u0438u0441u0443u0442u0441u0442u0432u0438u00a0 u043cu0434u043eu0440 u043fu0435u043fu0442u0438u0434u0430.;2. a set of reagents for 1, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 what is u0434u043bu00a0 quantitative u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 u043cu0434u043eu0440 u043fu0435u043fu0442u0438u0434u0430 in biological u0436u0438u0434u043au043eu0441u0442u00a0u0445 animals and humans.;3. a set of reagents for 1, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 what is u0434u043bu00a0 u043fu043eu043bu0443u043au043eu043bu0438u0447u0435u0441u0442u0432u0435u043du043du043eu0433u043e u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 u043cu0434u043eu0440 u043fu0435u043fu0442u0438u0434u0430 in biological u0436u0438u0434u043au043eu0441u0442u00a0u0445 animals and humans.;4. a set u043fu043f.2 and 3, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, biological fluids of humans and animals u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0442 a blood, plasma, cerebrospinal fluid, saliva and sweat.;5. a set u043fu043f.2 and 3, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 that contains polyclonal IgY, u0438u043cu043cu043eu0431u0438u043bu0438u0437u043eu0432u0430u043du043du044bu0435 on u043fu043eu043bu0438u043cu0435u0440u043du043eu043c medium.;6. a set u043fu043f.2 and 3, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 that contains polyclonal IgY, u0438u043cu043cu043eu0431u0438u043bu0438u0437u043eu0432u0430u043du043du044bu0435 on u043fu043eu043bu0438u0441u0442u0440u0438u0440u043eu043bu043eu0432u043eu043c u043bu0443u043du043eu0447u043du043eu043c tablet, u043du0438u0442u0440u043eu0446u0435u043bu043bu044eu043bu043eu0437u0435 or u043du0435u0439u043bu043eu043du0435.;7. a set u043fu043f.2 and 3, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 that contains human polyclonal igg, u0438u043cu043cu043eu0431u0438u043bu0438u0437u043eu0432u0430u043du043du044bu0435 on u043fu043eu043bu0438u043cu0435u0440u043du043eu043c medium.;8. a set u043fu043f.2 and 3, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 that contains human polyclonal igg, u0438u043cu043cu043eu0431u0438u043bu0438u0437u043eu0432u0430u043du043du044bu0435 on u043fu043eu043bu0438u0441u0442u0440u0438u0440u043eu043bu043eu0432u043eu043c u043bu0443u043du043eu0447u043du043eu043c tablet or u043du0438u0442u0440u043eu0446u0435u043bu043bu044eu043bu043eu0437u0435, u043du0435u0439u043bu043eu043du0435.;9. set 2, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 that contains a reagent u0434u043bu00a0 u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 u043fu0440u0438u0441u0443u0442u0441u0442u0432u0438u00a0 u043cu0434u043eu0440 u043fu0435u043fu0442u0438u0434u0430, u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0449u0438u0439 a u043au043eu043du044au044eu0433u0438u0440u043eu0432u0430u043du043du044bu0435 with u0444u043bu0443u043eu0440u0435u0441u0446u0435u0438u043du043eu043c gold or p u0435u0440u043eu043au0441u0438u0434u0430u0437u043eu0439 polyclonal igg.;10. set 3, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 that contains a reagent u0434u043bu00a0 u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 u043fu0440u0438u0441u0443u0442u0441u0442u0432u0438u00a0 u043cu0434u043eu0440 u043fu0435u043fu0442u0438u0434u0430, u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0449u0438u0439 a u043au043eu043du044au044eu0433u0438u0440u043eu0432u0430u043du043du044bu0435 with u0444u043bu0443u043eu0440u0435u0441u0446u0435u0438u043du043eu043c gold or p u0435u0440u043eu043au0441u0438u0434u0430u0437u043eu0439 goat antibodies against IgY.;11. set 2, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 order that contains the positive control sample u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0449u0438u0439 a u043bu0438u043eu0444u0438u043bu0438u0437u0438u0440u043eu0432u0430u043du043du044bu0439 powder synthetic u043cu0434u043eu0440 u043fu0435u043fu0442u0438u0434u0430, r u0430u0437u0432u0435u0434u0435u043du0438u0438 which u043fu043eu043bu0443u0447u0430u0435u0442u0441u00a0 1 ml of solution with concentration, u043eu0442u043du043eu0441u00a0u0449u0435u0439u0441u00a0 to disease.;12. set 2, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 that contains a negative control sample u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0449u0438u0439 a u043bu0438u043eu0444u0438u043bu0438u0437u0438u0440u043eu0432u0430u043du043du044bu0439 powder synthetic u043cu0434u043eu0440 u043fu0435u043fu0442u0438u0434u0430, r u0430u0437u0432u0435u0434u0435u043du0438u0438 which u043fu043eu043bu0443u0447u0430u0435u0442u0441u00a0 1 ml of solution with concentration, indicating the healthy persons, u0443u043fu043eu0442u0440u0435u0431u043bu00a0u044eu0449u0438u0445 drugs.;13. a set u043fu043f.2 and 3, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 that contains u043au0430u043bu0438u0431u0440u0430u0442u043eu0440, u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u044eu0449u0438u0439 a u043bu0438u043eu0444u0438u043bu0438u0437u0438u0440u043eu0432u0430u043du043du044bu0439 powder synthetic u043cu0434u043eu0440 u043fu0435u043fu0442u0438u0434u0430, for which p u043eu043bu0443u0447u0430u0435u0442u0441u00a0 concentrated solution.;14. a set u043fu043f.2 and 3, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, u043au0430u043bu0438u0431u0440u0430u0442u043eu0440, u043fu0440u0438u043cu0435u043du00a0u0435u043cu044bu0439 in u043fu00a0u0442u0438 u0440u0430u0437u0432u0435u0434u0435u043du0438u00a0u0445 u0434u043bu00a0 u043au043eu043du0442u0440u043eu043bu00a0 quality u0432u0445u043eu0434u00a0u0449u0438u0445 reagent in the kit.;15. a set u043fu043f.2 and 3, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, however, that the u0432u044bu00a0u0432u043bu0435u043du0438u00a0 healthy individuals not less than 98%.